Chinese Academy of Medical Sciences: Esophageal Neoplasms trials

The registry lists 25 Esophageal Neoplasms studies with Chinese Academy of Medical Sciences as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 9Phase 3 9No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer PatientsRecruitingNCT03731442Phase 3
• Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic ResectionCompletedNCT05499195
• Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 ResectionStatus unknownNCT05460403
• Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in ChinaCompletedNCT05194371
• Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction AdenocarcinomaStatus unknownNCT04140318Phase 2
• Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal CancerStatus unknownNCT04014465
• Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03Status unknownNCT03328234Phase 3
• Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02Status unknownNCT03308552Phase 3
• Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01CompletedNCT03298204
• Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT03083613Phase 2
• Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01CompletedNCT02979691Phase 2/3
• Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal CarcinomaStatus unknownNCT02858206Phase 2
• Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT02461043Phase 3
• Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic ApproachStatus unknownNCT02448979Phase 3
• Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic EsophagectomyStatus unknownNCT02448966
• Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node InvolvementStatus unknownNCT02448953Not applicable
• Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell CarcinomaCompletedNCT02446574Phase 1/2
• Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal CarcinomaCompletedNCT02429622Phase 1/2
• Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal CancerStatus unknownNCT02355249Phase 3
• Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 TrialStatus unknownNCT02319187Phase 3
• Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell CarcinomaCompletedNCT02133612Phase 2
• Endoscopic Screening on Esophageal CancerCompletedNCT02094105Not applicable
• Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;Status unknownNCT01745107Phase 3
• Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical TrialCompletedNCT01463605Phase 2
• A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and CisplatinStatus unknownNCT01444547Phase 2